Remibrutinib Open Label Roll-over Post-trial Access Protocol

Clinical trial NCT07456891 · RECRUITING

Trial details

NCT number: NCT07456891
Sponsor: Novartis Pharmaceuticals
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Indication of the Parent Protocol

Start date: 2026-04-16
Primary completion: 2033-01-30
Enrollment: 648

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.